Clinical trial
Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer
NCT00003928 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003928 |
|---|---|
| Title | Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer |
| Official title | A Phase II Study Utilizing Gemcitabine and Cisplatinum in Patients With Renal Cell Carcinoma |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, gemcitabine hydrochloride |
| Enrollment | 32 |
| Start date | Jan 1, 1999 |
| Primary completion | Feb 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 11, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: